Skip to Content

This producer of small heart pumps hasn’t missed a beat as the FDA approved Impella 2.5, a version of its flagship device for high-risk patients.

Company Information

Location
Danvers, MA
Industry
Medical Products & Equipment
Sector
Health Care
Fortune 500 Rank-
Fortune 500 Profile-
Current Streak1
Years on List1
CEO
Michael R. Minogue
Websitehttp://www.abiomed.com

Revenue, Net Income

Revenue Past Four Quarters230
Net Income Past Four Quarters114

Growth Rates

EPS 3 yr Annual Growth Rate65%
Rev 3 yr Annual Growth Rate20%
Total Return 3 yr Annual Rate42%
Beat S&P 3 yr Total Return?
yes

Rank

EPS Growth Rank34
Revenue Growth Rank87
Total Return Rank
50